Safety, efficacy and lessons from continuous infusion with rFVIIa

Haemophilia

Volumn 4, Issue 4, 1998, Pages 564-567

  Schulman, S ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activated factor VII; Continuous infusion; Haemophilia; Inhibitor

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG SAFETY; HEMOPHILIA; HUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 0031858822     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.440564.x     Document Type: Conference Paper

References (13)

1. Hedner U, Glazer S, Pingel K, Alberts KA, Blombäck M, Schulman S, Johnsson H. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy (letter). Lancet 1988; 2: 1193.
2. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994; 55: 638-48.
3. Hedner U. Dosing and monitoring of NovoSeven® treatment. Haemostasis 1996; 26 (Suppl 1): 102-8.
4. NovoSeven® Product Monograph, 1996.
5. McMillan CW, Webster WP, Roberts HR, Blythe WB. Continuous intravenous infusion of factor VIII in classic haemophilia. Br J Haematol 1970; 18: 659-67.
6. Schulman S, Bech Jensen M, Varon D, Keller N, Gitel S, Horoszowski H, et al. Feasibility of using recombinant factor VIIa in continuous infusion. Thromb Haemost 1996; 75: 432-6.
7. Schulman S, d'Oiron R, Martinowitz U, Pasi J, Briquel M-E, Mauser-Bunschoten E, et al. Experiences with continuous infusion of recombinant activated factor VII. Blood Coag Fibrinol; accepted for publication.
8. Martinowitz U, Schulman S. Continuous infusion of coagulation products. Int J Pediatr Hematol Oncol 1994; 1: 471-8.
9. Ingerslev J, Friedman D, Gastineau D, Gilchrist G, Johnsson H, Lucas G, et al. Major surgery in haemophilic patients with inhibitors using recombinant factor VIIa. Haemostasis 1996; 26 (Suppl 1): 118-23.
10. Makris M, Kitchen S, Russell F, Preston FE. Clinical use of activated recombinant factor VII concentrate (rFVIIa) and its in vivo monitoring. London: British Society for Haemostasis and Thrombosis and Nederlandse Vereniging voor Trombose en Hemostase, 1990; O 32 (abstract).
11. Lusher JM. Recombinant factor VIIa (NovoSeven®) in the treatment of internal bleeding in patients with factor VIII or IX inhibitors. Haemostasis 1996; 26 (suppl 1): 124-30.
12. Stieltjes N, Ounnoughene N, Vassilieff D, Sultan Y. Failure of recombinant factor VIIa to control surgical bleeding in a severe hemophilia A patient with an inhibitor and possible DIC. Thromb Haemost 1997; Suppl: 50 (abstr PS-202).
13. Tagariello G. www.haemophilia-forum.org; Questions and Answers, October 1997.